FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.1444.3.184

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113883.3.1444.3.184
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.184/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.184
Version20241127
Statusactive
Date2024-11-27T01:07:24-05:00
NameDurvalumabInjectable
TitleDurvalumab Injectable
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts of medication Durvalumab.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Durvalumab; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)

Resources that use this resource

ValueSet
2.16.840.1.113883.3.1444.5.229Minimal Emetic Risk Intravenous Antineoplastic Agent

Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.3.184",
  "meta": {
    "versionId": "11",
    "lastUpdated": "2024-11-27T01:07:24.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "American Society of Clinical Oncology Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-04-08"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-11-27"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.184",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.1444.3.184"
    }
  ],
  "version": "20241127",
  "name": "DurvalumabInjectable",
  "title": "Durvalumab Injectable",
  "status": "active",
  "date": "2024-11-27T01:07:24-05:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts of medication Durvalumab.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Durvalumab; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1919507",
            "display": "2.4 ML durvalumab 50 MG/ML Injection"
          },
          {
            "code": "1919515",
            "display": "10 ML durvalumab 50 MG/ML Injection"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:0629e977-bf27-438b-9ee7-cc54f67bdece",
    "timestamp": "2025-05-23T21:54:10-04:00",
    "total": 2,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1919507",
        "display": "2.4 ML durvalumab 50 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1919515",
        "display": "10 ML durvalumab 50 MG/ML Injection"
      }
    ]
  }
}